Literature DB >> 19117884

Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion.

Robin K Whyte1, Haresh Kirpalani, Elizabeth V Asztalos, Chad Andersen, Morris Blajchman, Nancy Heddle, Meena LaCorte, Charlene M T Robertson, Maxine C Clarke, Michael J Vincer, Lex W Doyle, Robin S Roberts.   

Abstract

BACKGROUND AND
OBJECTIVE: Extremely low birth weight infants frequently receive red cell transfusions. We sought to determine whether a restrictive versus liberal hemoglobin transfusion threshold results in differences in death or adverse neurodevelopmental outcomes of extremely low birth weight infants. PATIENTS AND METHODS: Extremely low birth weight infants previously enrolled in the Preterm Infants in Need of Transfusion Trial, a randomized, controlled trial of low versus high hemoglobin transfusion thresholds, were followed up at 18 to 21 months' corrected age. Erythrocyte transfusion was determined by an algorithm of low (restrictive) or high (liberal) hemoglobin transfusion thresholds, differing by 10 to 20 g/L and maintained until first hospital discharge. The primary composite outcome was death or the presence of cerebral palsy, cognitive delay, or severe visual or hearing impairment.
RESULTS: Of 451 enrolled infants, the primary outcome was available in 430. There was no statistically significant difference in the primary outcome, found in 94 (45%) of 208 in the restrictive group and 82 (38%) of 213 in the liberal group. There were no statistically significant differences in preplanned secondary outcomes. However, the difference in cognitive delay (Mental Development Index score < 70) approached statistical significance. A posthoc analysis with cognitive delay redefined (Mental Development Index score < 85) showed a significant difference favoring the liberal threshold group.
CONCLUSIONS: Maintaining the hemoglobin of extremely low birth weight infants at these restrictive rather than liberal transfusion thresholds did not result in a statistically significant difference in combined death or severe adverse neurodevelopmental outcome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19117884     DOI: 10.1542/peds.2008-0338

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  49 in total

Review 1.  Recommendations for transfusion therapy in neonatology.

Authors:  Gabriella Girelli; Stefano Antoncecchi; Anna Maria Casadei; Antonio Del Vecchio; Paola Isernia; Mario Motta; Daniela Regoli; Costantino Romagnoli; Gino Tripodi; Claudio Velati
Journal:  Blood Transfus       Date:  2015-07       Impact factor: 3.443

2.  A multidisciplinary "think tank": the top 10 clinical trial opportunities in transfusion medicine from the National Heart, Lung, and Blood Institute-sponsored 2009 state-of-the-science symposium.

Authors:  Cassandra D Josephson; Simone A Glynn; Steve H Kleinman; Morris A Blajchman
Journal:  Transfusion       Date:  2010-10-04       Impact factor: 3.157

3.  Acute physiological effects of packed red blood cell transfusion in preterm infants with different degrees of anaemia.

Authors:  Laura K Fredrickson; Edward F Bell; Gretchen A Cress; Karen J Johnson; M Bridget Zimmerman; Larry T Mahoney; John A Widness; Ronald G Strauss
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2010-11-20       Impact factor: 5.747

4.  Neurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion.

Authors:  Thomasin E McCoy; Amy L Conrad; Lynn C Richman; Scott D Lindgren; Peg C Nopoulos; Edward F Bell
Journal:  Child Neuropsychol       Date:  2011       Impact factor: 2.500

5.  Neonatal red blood cell transfusions: searching for better guidelines.

Authors:  Kavita Kasat; Karen D Hendricks-Muñoz; Pradeep V Mally
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

6.  Letters to the editor.

Authors:  David Gryn
Journal:  Paediatr Child Health       Date:  2014-11       Impact factor: 2.253

7.  Effects of anaemia on haemodynamic and clinical parameters in apparently stable preterm infants.

Authors:  Mirja Quante; Ferdinand Pulzer; Annett Bläser; Corinna Gebauer; Jens Kluge; Eva Robel-Tillig
Journal:  Blood Transfus       Date:  2012-07-11       Impact factor: 3.443

8.  Pharmacodynamically optimized erythropoietin treatment combined with phlebotomy reduction predicted to eliminate blood transfusions in selected preterm infants.

Authors:  Matthew R Rosebraugh; John A Widness; Demet Nalbant; Gretchen Cress; Peter Veng-Pedersen
Journal:  Pediatr Res       Date:  2013-11-11       Impact factor: 3.756

9.  Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo.

Authors:  Robin K Ohls; Beena D Kamath-Rayne; Robert D Christensen; Susan E Wiedmeier; Adam Rosenberg; Janell Fuller; Conra Backstrom Lacy; Mahshid Roohi; Diane K Lambert; Jill J Burnett; Barbara Pruckler; Hannah Peceny; Daniel C Cannon; Jean R Lowe
Journal:  Pediatrics       Date:  2014-05-12       Impact factor: 7.124

Review 10.  Darbepoetin Administration in Term and Preterm Neonates.

Authors:  Shrena Patel; Robin K Ohls
Journal:  Clin Perinatol       Date:  2015-05-23       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.